The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Amiodarone hepatotoxicity: Prevalence and clinicopathologic correlations among 104 patients
Abstract
The prevalence of apparent amiodarone-related hepatic injury in 104 patients followed prospectively is compared to that reported in the literature. Asymptomatic elevation of serum aminotransferase levels was detected in approximately one-fourth of the patients, a figure similar to the average of reported cases. The frequency of extrahepatic organ toxicity was increased in patients with elevated levels. Symptomatic “hepatitis” developed in 3% of this series and in less than 1% of cases in the litérature. Evidence of hepatic phospholipidosis and the development of pseudoalcoholic liver injury is most likely due to the biochemical effects of the drug and to possible metabolic idiosyncrasy, respectively. Serial blood enzyme measurements, as recommended by the manufacturer, may offer some protection against the development of more serious liver injury. However, levels of amiodarone may persist in various tissues for weeks to months following withdrawal, and stopping the drug does not guarantee the prompt reversal of any organ toxicity. Accordingly, the risks posed and benefits offered by amiodarone should be carefully weighed prior to discontinuing the drug, as the risk of sudden cardiac death may outweigh the hazards of ongoing hepatic, pulmonary or other toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hepatotoxicity. The adverse effects of drugs and other chemicals on the liver
(1980) · Food and Cosmetics Toxicology · doi:10.1016/0015-6264(80)90206-0 · Cited by 691
Hepatotoxicity: The adverse effects of drugs and other chemicals on the liver
Maddrey, W. C. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70192-2 · Cited by 646
Heger, J. J., Prystowsky, E. N., Jackman, W. M., Naccarelli, G. V., Warfel, K. A., Rinkenberger, R. L., & Zipes, D. P. (1981) · New England Journal of Medicine · doi:10.1056/nejm198109033051002 · Cited by 571
Oates, J. A., Wood, A. J. J., & Mason, J. W. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702193160807 · Cited by 412
Holt, D. W., Tucker, G. T., Jackson, P. R., & Storey, G. C. A. (1983) · American Heart Journal · doi:10.1016/0002-8703(83)90006-6 · Cited by 410
Burger, A., Dinichert, D., Nicod, P., Jenny, M., Lemarchand-Béraud, T., & Vallotton, M. B. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108466 · Cited by 312
MARCHLINSKI, F. E., GANSLER, T. S., WAXMAN, H. L., & JOSEPHSON, M. E. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-6-839 · Cited by 311
Lüllmann, H., Lüllmann-Rauch, R., Wassermann, O., & de la Iglesia, F. A. (1975) · CRC Critical Reviews in Toxicology · doi:10.1080/10408447509164014 · Cited by 291
Waxman, H. L., Groh, W. C., Marchlinski, F. E., Buxton, A. E., Sadowski, L. M., Horowitz, L. N., Josephson, M. E., & Kastor, J. A. (1982) · The American Journal of Cardiology · doi:10.1016/0002-9149(82)90419-2 · Cited by 249
Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias.
Haffajee, C. I., Love, J. C., Canada, A. T., Lesko, L. J., Asdourian, G., & Alpert, J. S. (1983) · Circulation · doi:10.1161/01.cir.67.6.1347 · Cited by 240
Cited by
Rinella, M. E., Neuschwander-Tetri, B. A., Siddiqui, M. S., Abdelmalek, M. F., Caldwell, S., Barb, D., Kleiner, D. E., & Loomba, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000323 · Cited by 2,667
Lee, W. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021844 · Cited by 1,594
EASL Clinical Practice Guidelines: Drug-induced liver injury
Andrade, R. J., Aithal, G. P., Björnsson, E. S., Kaplowitz, N., Kullak-Ublick, G. A., Larrey, D., & Karlsen, T. H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.02.014 · Cited by 1,276
Idiosyncratic drug hepatotoxicity
Kaplowitz, N. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1750 · Cited by 1,054
Andrade, R. J., Chalasani, N., Björnsson, E. S., Suzuki, A., Kullak-Ublick, G. A., Watkins, P. B., Devarbhavi, H., Merz, M., Lucena, M. I., Kaplowitz, N., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0105-0 · Cited by 924
Metadata
- Authors
- Lewis, J. H., Ranard, R. C., Caruso, A., Jackson, L. K., Mullick, F., Ishak, K. G., Seeff, L. B., & Zimmerman, H. J.
- Venue
- Hepatology
- Published
- 1989-05
- Volume
- 9
- Issue
- 5
- Pages
- 679-685
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1964153329
- Cited by
- 266
- References
- 32
- FWCI
- 3.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Amiodarone hepatotoxicity: Prevalence and clinicopathologic correlations among 104 patients. https://app.cochat.ai/papers/10.1002/hep.1840090504
- The paper
- Lewis, J. H., Ranard, R. C., Caruso, A., Jackson, L. K., Mullick, F., Ishak, K. G., Seeff, L. B., & Zimmerman, H. J. (1989). Amiodarone hepatotoxicity: Prevalence and clinicopathologic correlations among 104 patients. Hepatology. https://doi.org/10.1002/hep.1840090504
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.